tert-Butyl(1-benzhydrylazetidin-3-yl)carbamate
98%
- Product Code: 150814
CAS:
91189-18-3
| Molecular Weight: | 338.44 g./mol | Molecular Formula: | C₂₁H₂₆N₂O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD06409217 | |
| Melting Point: | Boiling Point: | 448.8±34.0 °C(Predicted) | |
| Density: | 1.13±0.1 g/cm3(Predicted) | Storage Condition: | 2-8°C, sealed, dry |
Product Description:
Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of central nervous system (CNS) agents. Its structure supports the creation of bioactive molecules due to the presence of a protected azetidine ring, which is valuable in medicinal chemistry for improving metabolic stability and solubility. Commonly employed in the preparation of drug candidates targeting neurological disorders, including antipsychotics and cognitive enhancers. Also utilized in research settings for scaffold modification in structure-activity relationship (SAR) studies.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | white solid |
| Purity (%) | 97.5-100 |
| Infrared Spectrum | Conforms to Structure |
| NMR | Conforms to Structure |
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 0.250 | 10-20 days | €14.55 |
+
-
|
| 1.000 | 10-20 days | €30.95 |
+
-
|
| 5.000 | 10-20 days | €110.83 |
+
-
|
| 25.000 | 10-20 days | €334.87 |
+
-
|
| 100.000 | 10-20 days | €967.05 |
+
-
|
tert-Butyl(1-benzhydrylazetidin-3-yl)carbamate
Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of central nervous system (CNS) agents. Its structure supports the creation of bioactive molecules due to the presence of a protected azetidine ring, which is valuable in medicinal chemistry for improving metabolic stability and solubility. Commonly employed in the preparation of drug candidates targeting neurological disorders, including antipsychotics and cognitive enhancers. Also utilized in research settings for scaffold modification in structure-activity relationship (SAR) studies.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
€0.00
€0.00
Total :